RT Journal Article
SR Electronic
T1 The effect of population mobility restrictive measures on the incidence of SARS-CoV-2 infection in the early phase of the pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.13.21255382
DO 10.1101/2021.04.13.21255382
A1 Luis Gustavo Modelli de Andrade
A1 Gustavo Fernandes Ferreira
A1 Helio Tedesco-Silva, Junior
YR 2021
UL http://medrxiv.org/content/early/2021/04/19/2021.04.13.21255382.abstract
AB Background This analysis aims to assess the association between population restrictive measures and the cumulative number of confirmed COVID-19 cases in the early phase of pandemic.Methods We compared mobility data extracted from the Mobility Reports provided by Google with the cumulative number of confirmed cases of COVID-19 of 15 countries provided by John Hopkins University. We compered the number of confirmed COVID-19 cases before and after the peak effect (PE) of population mobility restrictions in each country, defined as the highest percent reduction in mobility measurements.Results Time to PE of population mobility restrictions ranged between 16 and 45 days after the report of the index COVID-19 confirmed case in each country. The most frequent reductions in activities were retail & recreation, parks, and transit & stations, ranging from 30% to 90%. Despite this variability in PE among the countries, the predicted smooth effect after the PE of population mobility restrictions was observed in almost all countries.Conclusions These data suggest that the reduction in mobility was associated with a decrease in the cumulative total number of COVI-19 cases in each country, underscoring that the use of widely available real-time surveillance data might be a valuable resource during this pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectorsAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data set is publicly available, and ethics was not requiredAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data set used is publicly available https://github.com/CSSEGISandData/COVID-19 https://www.google.com/covid19/mobility/ 100K100,000EDFestimated degrees of freedomHDIhighest density intervalGAMgeneralized additive modelMCMCMarkov Chain Monte Carlo